|
|
| Nomenclature |
|
Symbol:
|
Tg(Sprr2f-cre)1Dcas
|
|
Name:
|
transgene insertion 1, Diego H Castrillon
|
|
MGI ID: |
MGI:4438222 |
|
Synonyms: |
Sprr2f-Cre |
|
Transgene:
|
Tg(Sprr2f-cre)1Dcas
Location:
unknown
|
|
Transgene
origin |
|
Transgene
description |
|
Transgene
Type: | |
Transgenic (Cre/Flp) |
|
Mutation: | |
Insertion |
| |
|
Mutation details: A 5.5 kb fragment of the Sprr2f promoter was cloned into a vector containing a cre coding sequence. The linearized construct was linearized and microinjected into FVB oocytes. Line 1 was assigned to this transgene in absence of specific line information. (J:158190)
|
|
|
Recombinase activity
|
|
Phenotypes
|
View phenotypes for all genotypes (concatenated display).
|
|
Disease models
|
|
| Find Mice (IMSR) |
Mouse strains and cell lines available from the
International Mouse Strain Resource
(IMSR)
|
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available |
|
| References |
|
Original: |
J:158190
Contreras CM et al.,
"Lkb1 inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapy."
Dis Model Mech 2010 Mar-Apr;3(3-4):181-93
|
|
All: |
1 reference(s)
|
|
Analysis Tools
